ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,449Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 392

$600K Total Retail Price of All Prescriptions

Rank: 7 out of 392

351 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Hampshire
Lower avg

Schedule Two
Controlled Substances

27% of this provider’s 351 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

11% of this provider’s 351 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

0% of this provider’s 4,645 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Hampshire
OXYCODONE HCL 464 64 S2 1 16
LISINOPRIL 325 203 2 1
SIMVASTATIN 263 198 3 2
OMEPRAZOLE 243 152 4 4
FUROSEMIDE 229 180 5 6
LEVOTHYROXINE SODIUM 187 109 6 3
AMLODIPINE BESYLATE 133 92 7 5
METOPROLOL TARTRATE 127 99 8 8
CITALOPRAM HBR 124 59 9 15
GABAPENTIN 118 37 10 18
ATORVASTATIN CALCIUM 118 87 10 10
TRAZODONE HCL 117 45 12 22
ZOLPIDEM TARTRATE 115 47 13 21
SPIRIVA 113 65 14 43
MORPHINE SULFATE ER 112 0 S2 15 71
HYDROCHLOROTHIAZIDE 105 85 16 7
METFORMIN HCL 103 72 17 9
PROAIR HFA 94 29 18 36
FENTANYL 83 19 S2 19 56
OXYCONTIN 83 14 S2 19 49
ADVAIR DISKUS 81 61 21 32
HYDROCODONE-ACETAMINOPHEN 80 34 S3 22 14
LOSARTAN POTASSIUM 80 61 22 20
OXYCODONE-ACETAMINOPHEN 77 28 S2 24 33
PANTOPRAZOLE SODIUM 75 39 25 24
WARFARIN SODIUM 73 56 26 12
FAMOTIDINE 72 51 27 76
TAMSULOSIN HCL 70 42 28 37
TRAMADOL HCL 67 12 29 25
PREDNISONE 66 39 30 39
CYMBALTA 64 11 31 52
KLOR-CON M20 64 44 31 63
PRAVASTATIN SODIUM 63 22 33 17
NAMENDA 63 46 33 40
ATENOLOL 62 40 35 11
DONEPEZIL HCL 61 61 36 29
CARVEDILOL 61 53 36 61
METOPROLOL SUCCINATE 60 42 38 13
MORPHINE SULFATE 60 24 S2 38 122
DILTIAZEM 24HR CD 59 57 40 105
MIRTAZAPINE 59 41 40 35
BYSTOLIC 58 40 42 168
MELOXICAM 57 31 43 62
GEMFIBROZIL 56 44 44 79
FLUOXETINE HCL 56 0 44 44
OXYCODONE HCL-ACETAMINOPHEN 54 11 S2 46 78
AMOX TR-POTASSIUM CLAVULANATE 54 28 46 140
LYRICA 54 13 46 138
ESCITALOPRAM OXALATE 53 16 49 54
ALLOPURINOL 52 28 50 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.